A combined approach for the early detection of ovarian cancer in asymptomatic women

G L Adonakis, Adonakis GL, George Adonakis, Paraskevaidis E, E Paraskevaidis, Evangelos Paraskevaidis, Tsiga S, Stamatia Tsiga, S Tsiga, Seferiadis K, K. Seferiadis, Dimitrios Lolis, D E Lolis, Lolis DE
European journal of obstetrics, gynecology, and reproductive biology · 1996 · vol. 65(2) , pp. 221–225 · doi:10.1016/0301-2115(95)02369-0 · PMID:8730628 · W2015439156
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper investigated a combined approach for the early detection of ovarian cancer in asymptomatic women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The purpose of this study was to investigate the effectiveness of the combined procedure including pelvic examination and serum CA-125 determination, as a screening method for the early detection of ovarian cancer. In 2000 women over 45 years old, without any evidence of adnexal disease, pelvic examination and serum CA-125 determination were performed. When either the findings of the pelvic examination were ambiguous or positive, or the serum CA-125 level was > 35 U/ml, further investigation including ultrasonography and laparoscopy or laparotomy was done. Among 174 women with clinical findings of adnexal disease there were 15 (8.62%) who had serum CA-125 > 35 U/ml. Among 18 women with elevated serum CA-125 (> 35 U/ml) there were 15 women (83.33%) who had clinical findings of adnexal disease. In 15 women further investigation was suggestive of adnexal disease and surgical exploration revealed three cases of malignancy. One case of serious ovarian cystadenocarcinoma stage Ia, one case of borderline ovarian tumour and one case of metastatic carcinoma from the right kidney. The other 12 women had benign adnexal masses or pelvic endometriosis. In our study this combined approach had sensitivity 100%, specificity 99.70% and P.P.V. 22%. According to these data, the procedure could be a potential component of a strategy aimed to the early detection of ovarian cancer, regardless of the financial cost.

My notes (saved in your browser only)

MeSH descriptors

CA-125 Antigen Mass Screening Ovarian Neoplasms Pelvis Physical Examination Aged Aged, 80 and over CA-125 Antigen Female Humans Mass Screening Middle Aged Ovarian Neoplasms Ovarian Neoplasms Physical Examination Predictive Value of Tests Time Factors Ultrasonography

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (17)

Cited by (2)

Source provenance

europepmc
last seen: 2026-08-18T06:10:16.649438+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:11:02.671803+00:00
unpaywall
last seen: 2026-08-18T06:27:49.008893+00:00
License: CC0 · commercial use OK